Zenakine

81 days ago

Skinbiotherapeutics: fake news? Share price drop

A, normally sensible, reader pings in his theory as to why shares in Skinbiotherapeutics (SBTX) are off by 12% today at 15.375p. He writes:

85 days ago

Skinbiotherapeutics and the rumoured Broker forecasts for Croda

Our in house bien pensant PL appears to have stumbled on forecasts from credible tier 1 brokers for how much revenue Croda (CRDA) will make from sales of the Skinbiotherapeutics (SBTX) product Zenakine. The source of this is, PL says, AI so it may be hogwash but it, perhaps, raises two critical points.

167 days ago

Skinbiotherapeutics – poor trading update and schoolboy accounting blunders

Skinbiotherapeutics (SBTX) later than expected trading update has been poorly received by investors: its not only a revenue miss but howling schoolboy errors by the new FD. This is another management clusterfuck and I shall elaborate n that in a bearcast special shortly.

294 days ago

CEOs do not decide the share price, Mr Market does, more cobblers from Stuart Ashman

I despair at the way that there is nobody with PLC experience to stop Skinbiotherapeutics (SBTX) CEO Stuart Ashman from making a complete tit of himself. Today there is another classic.